Don Joseph

Current

• Head of Corporate Development at ChemGenex (AUS: CXS)
• Strategic advisor, Corp Dev/Legal/Operations at Public/Private biopharmaceutical companies

Past

• Consultant--acting head of Corp Dev at Novacea
• COO at Institute for OneWorld Health
• SVP, Corp Dev & Gen Counsel at Renovis

3 more...

Education

• The University of Texas School of Law
• University of Oklahoma

Connections

64 connections

Industry

Biotechnology

Don Joseph’s Summary

Over 15 years in biotech/pharmaceutical industry, after 15 years in private law practice, in corporate, securities and commercial transactions and general business advice. Demonstrated track record of success in numerous transactions and projects, and in operational roles.

Recent industry transaction experience, acting as head of corporate development, general counsel or both, includes:
➢ Abgenix—acquisition by Amgen ($2.2 billion); co-lead, integration team
➢ ChemGenex—strategic alternative review and execution
➢ Novacea—reverse merger with private company, closed Q1’09
➢ OneWorld Health—led 4-way deal including sanofi-aventis, UC-Berkeley
➢ Private Bay Area company—renegotiation of strategic alliance
➢ Renovis—developed internal process leading to Evotec merger

Don Joseph’s Specialties:

Adding to management team expertise in counseling, structuring and execution of strategies for: M&A, out-licensing or in-licensing bio/pharma products, financing stratgies, and business/corporate development.

Don Joseph’s Experience

• Head of Corporate Development

  ChemGenex (AUS: CXS)

  (Biotechnology industry)

  February 2009 — Present (6 months)

  Leading corporate development function as consultant in ChemGenex's review of strategic alternatives for outlicensing, M&A and related transactions. Lead product is omacetaxine, in registration trial for chronic myeloid leukemia (CML).

• Strategic advisor, Corp Dev/Legal/Operations

  Public/Private biopharmaceutical companies

  (Biotechnology industry)

  March 2008 — Present (1 year 5 months)

  Providing transactional and operational strategy, process and negotiation advice to CEO/board of public and private companies.